Tectonic Therapeutic, Inc. (TECX) stock
TECXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$20.98−0.16 (-0.76%)
Close on Nov 16, 2026Market cap $410.15MP/E –Yield 0.00%
Tectonic Therapeutic revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
No revenue figures for Tectonic Therapeutic
Tectonic Therapeutic has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?